A new study predicts that annual costs associated with cancer treatment are expected to exceed $245 billion by 2030, nearly a 34% increase from 2015 billing. Specifically, medical care costs are expected to grow to $221 billion, with prescription drugs adding another $25 billion.
The article noted that earlier treatment means lower costs, while end-of-life treatment often has the largest expenses. MedBen WellLiving was designed with this fact in mind – to help you be proactive about cancer and other chronic diseases, rather than reactive. WellLiving has continuously outperformed national benchmarks as it pertains to member wellness compliance and cost.
If you are a current client, MedBen can review your plan performance with you, and target areas of possible vulnerability. If you are not currently a client but interested in how MedBen WellLiving can help you reduce cancer risk and high costs, contact us today at 888-627-8683.